Monitoring of cancer patients undergoing active or passive immunotherapy.
Salgaller
M L
ML
Immunotherapeutics Division, Northwest Biotherapeutics, L.L.C., Seattle, Washington 98125-7001, USA.
D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D006801:Humans; D006968:Hypersensitivity, Delayed; D007116:Immunization, Passive; D016233:Immunotherapy, Active; D015166:Monitoring, Immunologic / Q000379:methods*; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D000951:Antigens, Neoplasm